Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) issued its earnings results on Wednesday. Sarepta Therapeutics Stock Down 2.8%Shares of NASDAQ SRPT traded down $0.46 during midday trading on Wednesday, reaching $15.93. Sarepta Therapeutics has a 52-week low of $14.68 and a 52-week high of $25.32. Sarepta Therapeutics Company Profile(Get Free Report)Sarepta Therapeutics, Inc is a biopharmaceutical company focused on the discovery and development of precision genetic medicines for rare neuromuscular diseases. Sarepta’s commercial products include several exon-skipping therapies approved by the U.S.Read MoreReceive News & Ratings for Sarepta Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sarepta Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.